Pharma ~£350k in-year cash benefit and Operational Net Zero Carbon Pathway

30 Apr 2024
Carbon Reduction

Our appointment

 

BFY Carbon Strategies were engaged by a global biomedical components manufacturer to drive operational Net Zero Carbon across their European estate, focusing on high-impact efficiency measures and financial performance optimisation.

 

£350k in-year cash benefit: We uncovered facility layout changes left areas unnecessarily serviced by close-control HVAC systems, leading to excessive energy costs. Legacy gas-fired DHWS remained active despite localised electric heating solutions. A phased decommissioning plan was introduced to eliminate redundant infrastructure and cut waste. A technical strategy was developed to repurpose significant waste heat from cooling and heating systems into steam and LTWH systems.

Net Operating Income (NOI) Improvement: Implementing onsite renewable generation and efficiency measures reduces operational costs, directly enhancing NOI. With £350k in annual savings, projected long-term reductions exceed £3.5m over a 10-year period, strengthening asset value and financial resilience.

About the development

 

The client site integrates advanced R&D and full-scale manufacturing. The project aligns with strategic sustainability goals, reinforcing operational resilience while accelerating carbon reduction commitments.

 

 

Share Post

Meet the Team

Our Carbon Strategies Team

Ian Barker

Managing Partner

Ian shapes the vision for Carbon Strategies and BFY Group - inspiring the team to deliver exceptional results.

View Profile